Medical condition
Plaque Psoriasis
Plaque Psoriasis is a medical condition tracked by NovaPharmaNews across 12 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- dimethyl fumarate (APO-DIMETHYL FUMARATE) Antineoplastic and immunomodulating agents (L04)
- tildrakizumab (ILUMYA) Antineoplastic and immunomodulating agents (L04)
- apremilast (OTEZLA) Antineoplastic and immunomodulating agents (L04)
- guselkumab (TREMFYA) Antineoplastic and immunomodulating agents (L04)
- ixekizumab (TALTZ) Antineoplastic and immunomodulating agents (L04)
- deucravacitinib (SOTYKTU) Antineoplastic and immunomodulating agents (L04)
- etanercept (BRENZYS) Antineoplastic and immunomodulating agents (L04)
- brodalumab (KYNTHEUM) Antineoplastic and immunomodulating agents (L04)
- secukinumab (COSENTYX) Antineoplastic and immunomodulating agents (L04)
- ustekinumab (STELARA) Antineoplastic and immunomodulating agents (L04)
- infliximab (INFLECTRA) Antineoplastic and immunomodulating agents (L04)
- bimekizumab (BIMZELX) Antineoplastic and immunomodulating agents (L04)